| Product Code: ETC9690835 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Oncology Active Pharmaceutical Ingredients (APIs) Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Oncology Active Pharmaceutical Ingredients (APIs) Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Oncology Active Pharmaceutical Ingredients (APIs) Market - Industry Life Cycle |
3.4 Thailand Oncology Active Pharmaceutical Ingredients (APIs) Market - Porter's Five Forces |
3.5 Thailand Oncology Active Pharmaceutical Ingredients (APIs) Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Thailand Oncology Active Pharmaceutical Ingredients (APIs) Market Revenues & Volume Share, By Manufacturer Type, 2021 & 2031F |
3.7 Thailand Oncology Active Pharmaceutical Ingredients (APIs) Market Revenues & Volume Share, By Type of Synthesis, 2021 & 2031F |
3.8 Thailand Oncology Active Pharmaceutical Ingredients (APIs) Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 Thailand Oncology Active Pharmaceutical Ingredients (APIs) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Thailand |
4.2.2 Growing demand for oncology treatments |
4.2.3 Advancements in oncology research and development |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for API approval |
4.3.2 High cost associated with oncology API production |
4.3.3 Limited availability of skilled workforce in oncology API manufacturing |
5 Thailand Oncology Active Pharmaceutical Ingredients (APIs) Market Trends |
6 Thailand Oncology Active Pharmaceutical Ingredients (APIs) Market, By Types |
6.1 Thailand Oncology Active Pharmaceutical Ingredients (APIs) Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Thailand Oncology Active Pharmaceutical Ingredients (APIs) Market Revenues & Volume, By Drug Type, 2021- 2031F |
6.1.3 Thailand Oncology Active Pharmaceutical Ingredients (APIs) Market Revenues & Volume, By Innovative Oncology APIs, 2021- 2031F |
6.1.4 Thailand Oncology Active Pharmaceutical Ingredients (APIs) Market Revenues & Volume, By Generic Oncology APIs, 2021- 2031F |
6.2 Thailand Oncology Active Pharmaceutical Ingredients (APIs) Market, By Manufacturer Type |
6.2.1 Overview and Analysis |
6.2.2 Thailand Oncology Active Pharmaceutical Ingredients (APIs) Market Revenues & Volume, By Captive Manufacturers, 2021- 2031F |
6.2.3 Thailand Oncology Active Pharmaceutical Ingredients (APIs) Market Revenues & Volume, By Merchant Manufacturers, 2021- 2031F |
6.3 Thailand Oncology Active Pharmaceutical Ingredients (APIs) Market, By Type of Synthesis |
6.3.1 Overview and Analysis |
6.3.2 Thailand Oncology Active Pharmaceutical Ingredients (APIs) Market Revenues & Volume, By Synthetic Oncology APIs, 2021- 2031F |
6.3.3 Thailand Oncology Active Pharmaceutical Ingredients (APIs) Market Revenues & Volume, By Biotech Oncology APIs, 2021- 2031F |
6.4 Thailand Oncology Active Pharmaceutical Ingredients (APIs) Market, By Indication |
6.4.1 Overview and Analysis |
6.4.2 Thailand Oncology Active Pharmaceutical Ingredients (APIs) Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.4.3 Thailand Oncology Active Pharmaceutical Ingredients (APIs) Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.4.4 Thailand Oncology Active Pharmaceutical Ingredients (APIs) Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.4.5 Thailand Oncology Active Pharmaceutical Ingredients (APIs) Market Revenues & Volume, By Prostate Cancer, 2021- 2031F |
6.4.6 Thailand Oncology Active Pharmaceutical Ingredients (APIs) Market Revenues & Volume, By Stomach Cancer, 2021- 2031F |
6.4.7 Thailand Oncology Active Pharmaceutical Ingredients (APIs) Market Revenues & Volume, By Liver Cancer, 2021- 2031F |
6.4.8 Thailand Oncology Active Pharmaceutical Ingredients (APIs) Market Revenues & Volume, By Others, 2021- 2031F |
6.4.9 Thailand Oncology Active Pharmaceutical Ingredients (APIs) Market Revenues & Volume, By Others, 2021- 2031F |
7 Thailand Oncology Active Pharmaceutical Ingredients (APIs) Market Import-Export Trade Statistics |
7.1 Thailand Oncology Active Pharmaceutical Ingredients (APIs) Market Export to Major Countries |
7.2 Thailand Oncology Active Pharmaceutical Ingredients (APIs) Market Imports from Major Countries |
8 Thailand Oncology Active Pharmaceutical Ingredients (APIs) Market Key Performance Indicators |
8.1 Research and development investment in oncology APIs |
8.2 Number of new oncology API product launches |
8.3 Adoption rate of innovative oncology API technologies |
9 Thailand Oncology Active Pharmaceutical Ingredients (APIs) Market - Opportunity Assessment |
9.1 Thailand Oncology Active Pharmaceutical Ingredients (APIs) Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Thailand Oncology Active Pharmaceutical Ingredients (APIs) Market Opportunity Assessment, By Manufacturer Type, 2021 & 2031F |
9.3 Thailand Oncology Active Pharmaceutical Ingredients (APIs) Market Opportunity Assessment, By Type of Synthesis, 2021 & 2031F |
9.4 Thailand Oncology Active Pharmaceutical Ingredients (APIs) Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Thailand Oncology Active Pharmaceutical Ingredients (APIs) Market - Competitive Landscape |
10.1 Thailand Oncology Active Pharmaceutical Ingredients (APIs) Market Revenue Share, By Companies, 2024 |
10.2 Thailand Oncology Active Pharmaceutical Ingredients (APIs) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here